BridgeMD
New treatment option for Symptomatic Irreversible Pulpitis
Official title Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis
ClinicalTrials.gov ID: NCT06525844
What this study is testing
- What it's testing
- Root canal therapy (RCT) is a classical and effective treatment that is currently utilised in dental practice, offering high success rates for pulp and periapical diseases; however, teeth after RCT are susceptible to altered pulp defence and sensory function, even fractures, as a consequence of pulp loss. Furthermore, several studies have highlighted that the actual failure rate of standard root canal treatments performed in general practice is significantly higher than expected .
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35
You may be able to join if
- Patients from both genders with an age range of 18-35 years old.
- Permanent teeth with mature roots with a diagnosis of irreversible pulpitis, with absorption damage to the apex, and the diameter of the apical hole...
- A restorable tooth.
- There is no need to leave space for the final post/core restoration.
- Anterior teeth and premolars with single canal.
You likely can't join if
- Patients with other serious organ diseases, such as cardiopulmonary, kidney and other major diseases.
- Pregnant women or lactating or expecting within a year.
- Patients with apical cysts.
- Patients with poor cooperation and those who quit the study halfway.
- Patients with periodontitis.
- Patients with dental dysplasia or other oral genetic disorders.
See the full eligibility criteria
- Patients from both genders with an age range of 18-35 years old.
- Permanent teeth with mature roots with a diagnosis of irreversible pulpitis, with absorption damage to the apex, and the diameter of the apical hole is greater than 1 mm.
- A restorable tooth.
- There is no need to leave space for the final post/core restoration.
- Anterior teeth and premolars with single canal.
- A cooperative and compliant patient.
- Patients not allergic to the drugs and antibiotics which needed to complete treatment.
- No periodontal disease or root cracking.
- Patients with other serious organ diseases, such as cardiopulmonary, kidney and other major diseases.
- Pregnant women or lactating or expecting within a year.
- Patients with apical cysts.
- Patients with poor cooperation and those who quit the study halfway.
- Patients with periodontitis.
- Patients with dental dysplasia or other oral genetic disorders.
- Patients with dental phobia.
- Patients with mental disorders.
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, ICT, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, ICT, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.